Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

ClinicalTrials.gov ID: NCT04406649

Public ClinicalTrials.gov record NCT04406649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 3:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study STS101-003 is a multi-center, multiple dose (PRN), open-label, 12-month study to evaluate the safety and tolerability of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

Study identification

NCT ID
NCT04406649
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Satsuma Pharmaceuticals, Inc.
Industry
Enrollment
482 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2020 (Actual)
Primary completion
Jan 16, 2023 (Actual)
Completion
Jan 16, 2023 (Actual)
Last update posted
Jul 3, 2023

2020 – 2023

United States locations

U.S. sites
44
U.S. states
21
U.S. cities
43
Facility City State ZIP Site status
WR-PRI Encino California 91316 —
Collaborative Neuroscience Long Beach California 90806 —
WR-PRI Los Alamitos California 90720 —
Downtown LA Research Los Angeles California 90017 —
Clinical Research Institute Los Angeles California 90048 —
WR-PRI Newport Beach California 92660 —
Hillcrest Medical Research DeLand Florida 32720 —
MD Clinical Hallandale Florida 33009 —
Multi-Specialty Research Associates Lake City Florida 32055 —
ClinCloud Maitland Florida 32751 —
Biotech Pharmaceuticals Miami Florida 33155 —
Behavioral Clinical Research Miami Lakes Florida 33061 —
CNS Health Care - Orlando Orlando Florida 32801 —
Complete Health Research Ormond Beach Florida 32174 —
Infinity Clinical Research Sunrise Florida 33351 —
Santos Research Center, Corp Tampa Florida 33615 —
Palm Beach Research Center West Palm Beach Florida 33409 —
Clinical Research CF Winter Haven Florida 33880 —
Advanced Clinical Research Meridian Idaho 83642 —
Integrated Clinical Trial Services, Inc West Des Moines Iowa 50265 —
Delricht Research Prairieville Louisiana 70769 —
Medvadis Research at Boston PainCare Center Waltham Massachusetts 02451 —
Healthcare Research Network Hazelwood Missouri 63042 —
Clinvest Research Springfield Missouri 65810 —
Montana Medical Research Missoula Montana 59808 —
Wake Research - Clinical Research Center of Nevada Las Vegas Nevada 89118 —
Dartmouth-Hitchcock Neurology Headache Clinic Lebanon New Hampshire 03766 —
Hassman Research Institute Berlin New Jersey 08009 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
SPRI Clinical Research Brooklyn New York 11235 —
Montefiore Medical Center The Bronx New York 10461 —
PharmQuest Greensboro North Carolina 27408 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Rapid Medical Research Cleveland Ohio 44122 —
Neurology Diagnosis Dayton Ohio 45459 —
Delricht Research Tulsa Oklahoma 74133 —
Thomas Jefferson University/Jefferson Headache Center Philadelphia Pennsylvania 19107 —
Omega Medical Research Warwick Rhode Island 02886 —
CNS Healthcare - Memphis Memphis Tennessee 38119 —
FutureSearch Trials of Neurology Austin Texas 78731 —
DM Clinical Research Tomball Texas 77375 —
Charlottesville Medical Research Charlottesville Virginia 22911 —
Georgetown University Hospital, Department of Neurology McLean Virginia 22101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04406649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2023 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04406649 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →